Trevor Bushell, Ph.D.

University of Strathclyde, Glasgow, Scotland, United Kingdom 
"Trevor Bushell"
Mean distance: 14.7 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pytka K, Dawson N, Tossell K, et al. (2020) Mitogen-activated protein kinase phosphatase-2 deletion modifies ventral tegmental area function and connectivity and alters reward processing. The European Journal of Neuroscience
Ritchie L, Tate R, Chamberlain LH, et al. (2018) Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons. Neuropharmacology
Cain SM, Garcia E, Waheed Z, et al. (2017) GABAB Receptors Suppress Burst-Firing in Reticular Thalamic Neurons. Channels (Austin, Tex.). 0
Cunningham M, McIntosh K, Bushell T, et al. (2016) Proteinase-activated receptors (PARs) as targets for antiplatelet therapy. Biochemical Society Transactions. 44: 606-12
Abdul Rahman NZ, Greenwood SM, Brett RR, et al. (2016) Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 2348-54
Bushell TJ, Cunningham MR, McIntosh KA, et al. (2015) Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders? Current Drug Targets
Shrestha R, Shakya Shrestha S, Millingtona O, et al. (2014) Immune responses in neurodegenerative diseases. Kathmandu University Medical Journal (Kumj). 12: 67-76
Shrestha R, Millington O, Brewer J, et al. (2014) Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways. Neuropharmacology. 76: 184-93
Shrestha R, Millington O, Brewer J, et al. (2013) Lymphocytes protect cortical neurons against excitotoxicity mediated by kainic acid, an in vitro model for neurodegeneration. Kathmandu University Medical Journal (Kumj). 11: 132-8
Shrestha R, Millington O, Brewer J, et al. (2013) Is central nervous system an immune-privileged site? Kathmandu University Medical Journal (Kumj). 11: 102-7
See more...